Patent application number | Description | Published |
20090042892 | Cetp Inhibitors - Compounds having the structure of Formula (I), including pharmaceutically acceptable salts of the compounds, are CETP inhibitors and are useful for raising HDL-cholesterol, reducing LDL-cholesterol, and for treating or preventing atherosclerosis. In the compounds of Formula (I), B is a cyclic group other than phenyl, and B has a cyclic substituent at a position that is ortho to the position at which B is connected to the remainder of the structure of Formula (I). The 5-membered ring of Formula (I) has a second cyclic substituent in addition to B. | 02-12-2009 |
20090075979 | CETP Inhibitors - Compounds having the structure of Formula (I), including pharmaceutically acceptable salts of the compounds, are CETP inhibitors, and are useful for raising HDL-cholesterol, reducing LDL-cholesterol, and for treating or preventing atherosclerosis. In the compounds of Formula (I), B or R | 03-19-2009 |
20090124689 | CETP Inhibitors - Compounds having a biphenyl group substituted with a phenyl or heteroaromatic group, as shown in Formula I, including pharmaceutically acceptable salts of the compounds, are CETP inhibitors, and are useful for raising HDL-cholesterol, reducing LDL-cholesterol, and for treating or preventing atherosclerosis: | 05-14-2009 |
20090137548 | 1,3-Oxazolidin-2-One Derivatives Useful as Cetp Inhibitors - Compounds having the structure of Formula I, including pharmaceutically acceptable salts of the compounds, are CETP inhibitors, and are useful for raising HDL-cholesterol, reducing LDL-cholesterol, and for treating or preventing atherosclerosis. The compounds have 3 cyclic groups connected by single bonds, as for example triphenyl, which are attached directly to the ring of formula I or attached at the position B. | 05-28-2009 |
20100099716 | CETP INHIBITORS - Compounds having the structures of Formula I, including pharmaceutically acceptable salts of the compounds, are CETP inhibitors, and are useful for raising HDL-cholesterol, reducing LDL-cholesterol, and for treating or preventing atherosclerosis: | 04-22-2010 |
20110178059 | 1,3-OXAZOLIDIN -2-ONE DERIVATIVES USEFUL AS CETP INHIBITORS - Compounds having the structure of Formula I, including pharmaceutically acceptable salts of the compounds, are CETP inhibitors, and are useful for raising HDL-cholesterol, reducing LDL-cholesterol, and for treating or preventing atherosclerosis. The compounds have 3 cyclic groups connected by single bonds, as for example triphenyl, which are attached directly to the ring of formula I or attached at the position B. | 07-21-2011 |
20130072492 | SOLUBLE GUANYLATE CYCLASE ACTIVATORS - A compound of Formula (I): or a pharmaceutically acceptable salt thereof, are capable of modulating the body's production of cyclic guanosine monophosphate (“cGMP”) and are generally suitable for the therapy and prophylaxis of diseases which are associated with a disturbed cGMP balance. The invention furthermore relates to processes for preparing compounds of Formula I, or a pharmaceutically acceptable salt thereof, for their use in the therapy and prophylaxis of the abovementioned diseases and for preparing pharmaceuticals for this purpose, and to pharmaceutical preparations which comprise compounds of Formula (I) or a pharmaceutically acceptable salt thereof. | 03-21-2013 |
20130331372 | Cyclic Amine Substituted Oxazolidinone CETP Inhibitor - Compounds having the structure of Formula I, including pharmaceutically acceptable salts of the compounds, are CETP inhibitors and are useful for raising HDL-cholesterol, reducing LDL-cholesterol, and for treating or preventing atherosclerosis. In the compound of Formula I, A | 12-12-2013 |
20140221383 | CETP INHIBITORS - Compounds having the structures of Formula I, including pharmaceutically acceptable salts of the compounds, are CETP inhibitors, and are useful for raising HDL-cholesterol, reducing LDL-cholesterol, and for treating or preventing atherosclerosis: | 08-07-2014 |
20150322056 | Factor IXa Inhibitors - The present invention provides a compound of Formula (I) | 11-12-2015 |
20150329562 | Factor IXa Inhibitors - The present invention provides a compound of Formula (I) | 11-19-2015 |
20150368269 | Factor IXa Inhibitors - The present invention provides a compound of Formula (I) | 12-24-2015 |
Patent application number | Description | Published |
20090231016 | GATE OXIDE PROTECTED I/O CIRCUIT - An integrated circuit comprises a first input node and a second input node, an output node; a first output transistor of a first type and a second output transistor of a second type, and a first clamping transistor of the second type and a second clamping transistor of a second type. The first clamping transistor, the first output transistor, the second clamping transistor, and the second output transistor are coupled in series across a first power supply terminal and a second power supply terminal. The first input node is coupled to a gate of the first output transistor. The second input node is coupled to a gate of the second output transistor. The output node is coupled to a common node of the first output transistor and the second clamping transistor. A gate of the first clamping transistor is coupled to a first reference voltage. A gate of the second clamping transistor is coupled to a second reference voltage. | 09-17-2009 |
20110175684 | TEMPERATURE-COMPENSATED RING OSCILLATOR - A temperature-compensated ring oscillator includes a control signal generator and a voltage controlled oscillator. The control signal generator is configured to generate at least one control signal, and includes at least one first resistor and second resistor. A first temperature coefficient of the first resistor is negative, and a second temperature coefficient of the second resistor is positive. The voltage controlled oscillator receives the control signal, outputs an oscillation signal, and has (2 | 07-21-2011 |
20120133396 | COMPARATOR - A comparator comprises a current mirror, a differential input pair, and a auxiliary circuit. The current mirror has a biasing end coupled to a power voltage, a first end, and a current outputting end coupled to an output node of the comparator. The differential input pair has a first and second input ends for respectively receiving a first voltage and a second voltage, a second and third ends, and a ground end, wherein the third end is coupled to the first end. The auxiliary circuit is coupled between the output node and the second end, and provides a minimum voltage of a comparison result output at the output node. The comparison result is the power voltage when the first voltage is larger than the second voltage, and the comparison result is the minimum voltage when the first voltage is less than the second voltage. | 05-31-2012 |
20120146601 | VOLTAGE DIVIDER CIRCUIT AND VOLTAGE REGULATOR - The invention provides a voltage regulator including a voltage divider and a power supply. The voltage divider circuit includes a first, second, third PMOS transistors, a first NMOS transistor, a pull down circuit, and a switching capacitor circuit. The pull down circuit includes a plurality of switches controlled by a pull down control signal. The switching capacitor circuit controlled by a first control pulse includes a capacitor and provides the capacitor connected to the dividing voltage for a short period while the power supply starts up to provide the input voltage. The power supply includes a comparator and a power voltage switch. The comparator compares the dividing voltage and a reference voltage and outputs a comparison result correspondingly. The power voltage switch is controlled by the comparison result to provide the input voltage from a power voltage. | 06-14-2012 |